Cancer Drug Resistance
@cdrjournal
Followers
865
Following
962
Media
1K
Statuses
1K
Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 Pharmacology(medical). Indexed in PubMed Central(PMC), ESCI and Scopus #Cancer #DrugResistance
Beijing, China
Joined September 2020
🎉 CDR Impact Factor hits 5.2!. Now ranked Q1 in Oncology (64/326). ⬆️ Up 13% from last year (4.6). Proud to be the only journal focused on cancer drug resistance. Huge thanks to our contributors and our amazing Editorial Board!👏. 🔗More details here:
0
3
10
🔎This is an article about ovarian cancer in #Cancer #DrugResistance. 👉Title: Ivosidenib enhances #cisplatin sensitivity in #OvarianCancer by reducing cancer cell stemness. ✨Key words: Ivosidenib, cancer stem cells, et al. 📩Read more:
0
0
0
✨If you are interested in #ColorectalCancer, don't miss this article in #Cancer #DrugResistance!. 👉Title: Unveiling #MAGEA3: a novel predictive #biomarker for #bevacizumab resistance in colorectal cancer. 🔗Read the full article:
0
0
0
👏Newly published in #Cancer #DrugResistance!. 💡This review covers the development, challenges, and future opportunities of #Antibody drug #Conjugates (ADCs). 🔗Read for free:
0
0
0
🧠 Why does #HCC remain so hard to treat?. 📷New insights point to the tumor microenvironment (#TME) as a key player in #therapy #resistance. 📖 Read the full article in Cancer Drug Resistance:
0
2
3
💥New in #Cancer #DrugResistance !. 🔑As powerful 3D models, tumor organoids are redefining preclinical cancer research. 💡This review covers #Modeling techniques and their use in #DrugScreening and studying #Resistance mechanisms. 👉Download PDF:
0
0
0
💥New in #Cancer #DrugResistance：. Multi-omics reveal immune-driven drug resistance and metabolic targets in #ProstateCancer precise prognosis and tailored therapy. 🔍Keywords.Tumor microenvironment, immunotherapy, prognostic model etc. 📖Read more:
0
0
0
#FGFR1 overexpression drives #resistance to the #PI3K #inhibitor #alpelisib in #ER+ #breastcancer via RTK–ER signaling crosstalk. 💡 The fix? A triple combo: #alpelisib + #AZD4547 + #fulvestrant = strong synergy & restored sensitivity. 🔗Read for free:
0
4
4
🎯 Can #microRNAs overcome #drug_resistance in #thyroid #cancer?. 📖New in Cancer Drug Resistance. 🧬Title: MicroRNA-mediated #autophagy #regulation in thyroid cancer drug resistance. 🔗 Read for free and download PDF:
0
2
2
🎯 #Antibody #drug #Conjugates in #BreastCancer: Can They Outsmart #Resistance ?. 📘 The latest published #review: Antibody-drug conjugates in breast cancer: current resistance mechanisms and future #combination #strategies. 📖 Read for free:
0
3
3
🔬 New Review Alert: Advances in the application of #patient_derived #xenograft models in #acute #leukemia #Resistance . 📘 Read the full review to dive into: #Cancer #DrugResistance . 📖Read for free: 🔗 Download PDF:
0
0
0
🧬 New study alert!#Cancer #Drug #Resistance. ⁉️ What drives #tumor #aggressiveness and #resistance to systemic #therapies in #hepatocellular #carcinoma (#HCC)? Could the Period 2 (#PER2) in aggressiveness hold the answer? 🕒. 📖Read now:
0
0
1
🧬 New study shows: #FGFR #inhibitor #Infigratinib blocks growth, migration & activates cell death—offering hope for precision therapy in kids' #cancers. Unique insights from Ivan Li（@TuftsUniversity）, Peter E. Zage, MD, PhD(@UCSDCancer ) et al. 🔗View:
0
0
0
This review is not to be missed! An in-depth look at emerging strategies to overcome drug resistance, including multi-targeted therapies, combination therapies, and the application of synthetic lethal effects, provides valuable insights. Worth reading!.
0
5
7
🆕Thrilled to share this excellent new review from researchers at @BrownUCancer @BrownMedicine @BrownUnivHealth @BrownPathology @MSMEDU ！ 👏🎉🎉Congratulations to the authors!.
Very pleased to share our review just published in @cdrjournal from #LegorretaCancerCenter @BrownUCancer @BrownMedicine @BrownUnivHealth @BrownPathology @MSMEDU “Acquired resistance to molecularly targeted therapies for cancer”
0
3
6
RT @weldeiry: Very pleased to share our review just published in @cdrjournal from #LegorretaCancerCenter @BrownUCancer @BrownMedicine @Bro….
0
12
0
🎉Cancer Drug Resistance Reaches New Heights - 2024 #CiteScore of 8.3 — a 25.8% jump!.💡Ranked #36/275 in Pharmacology (Medical) – top 13% globally! Thanks to our authors, editors & reviewers for powering this breakthrough. #Oncology #Cancer #pharmacology
0
3
7
🎗 June is National Cancer Survivor Month! Cancer Drug Rresistance offers a limited-time APC discount to support researchers in the vital field of cancer #drug resistance. 🔬 Global researchers welcome.📩 Submit now.🌐 #NationalCancerSurvivorMonth #Cancer
0
0
1
Dr. Junhua Mai.Houston Methodist Research Institute, Houston, United States.Topic: Overcoming multidrug-resistant tumors with polymeric platinum drugs with novel ROS-stimulating activity.Tune in to hear the expert's speech:.
0
0
1